455 related articles for article (PubMed ID: 29572682)
21. In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
Molla A; Kati W; Carrick R; Steffy K; Shi Y; Montgomery D; Gusick N; Stoll VS; Stewart KD; Ng TI; Maring C; Kempf DJ; Kohlbrenner W
J Virol; 2002 Jun; 76(11):5380-6. PubMed ID: 11991966
[TBL] [Abstract][Full Text] [Related]
22. In vitro neuraminidase inhibitory concentration (IC
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2017 Sep; 23(9):609-614. PubMed ID: 28655503
[TBL] [Abstract][Full Text] [Related]
23. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
[TBL] [Abstract][Full Text] [Related]
24. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
[TBL] [Abstract][Full Text] [Related]
25. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
[TBL] [Abstract][Full Text] [Related]
26. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Sidwell RW; Huffman JH; Barnard DL; Bailey KW; Wong MH; Morrison A; Syndergaard T; Kim CU
Antiviral Res; 1998 Feb; 37(2):107-20. PubMed ID: 9588843
[TBL] [Abstract][Full Text] [Related]
28. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
[TBL] [Abstract][Full Text] [Related]
29. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.
Abed Y; Pizzorno A; Bouhy X; Boivin G
Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229
[TBL] [Abstract][Full Text] [Related]
30. A Balance between Inhibitor Binding and Substrate Processing Confers Influenza Drug Resistance.
Jiang L; Liu P; Bank C; Renzette N; Prachanronarong K; Yilmaz LS; Caffrey DR; Zeldovich KB; Schiffer CA; Kowalik TF; Jensen JD; Finberg RW; Wang JP; Bolon DNA
J Mol Biol; 2016 Feb; 428(3):538-553. PubMed ID: 26656922
[TBL] [Abstract][Full Text] [Related]
31. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
Fujisaki S; Takashita E; Yokoyama M; Taniwaki T; Xu H; Kishida N; Sato H; Tashiro M; Imai M; Odagiri T
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):51-6. PubMed ID: 23131559
[TBL] [Abstract][Full Text] [Related]
32. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
[TBL] [Abstract][Full Text] [Related]
33. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
[TBL] [Abstract][Full Text] [Related]
34. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
[TBL] [Abstract][Full Text] [Related]
35. Identification of a Permissive Secondary Mutation That Restores the Enzymatic Activity of Oseltamivir Resistance Mutation H275Y.
Jiang L; Samant N; Liu P; Somasundaran M; Jensen JD; Marasco WA; Kowalik TF; Schiffer CA; Finberg RW; Wang JP; Bolon DNA
J Virol; 2022 Mar; 96(6):e0198221. PubMed ID: 35045267
[TBL] [Abstract][Full Text] [Related]
36. Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Ikematsu H; Kawai N
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):851-7. PubMed ID: 21973296
[TBL] [Abstract][Full Text] [Related]
37. The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses.
Leneva IA; Roberts N; Govorkova EA; Goloubeva OG; Webster RG
Antiviral Res; 2000 Nov; 48(2):101-15. PubMed ID: 11114412
[TBL] [Abstract][Full Text] [Related]
38. Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.
McKimm-Breschkin JL; Barrett S; McKenzie-Kludas C; McAuley J; Streltsov VA; Withers SG
Antiviral Res; 2019 Sep; 169():104542. PubMed ID: 31233807
[TBL] [Abstract][Full Text] [Related]
39. Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS).
Whitley RJ; Boucher CA; Lina B; Nguyen-Van-Tam JS; Osterhaus A; Schutten M; Monto AS
Clin Infect Dis; 2013 May; 56(9):1197-205. PubMed ID: 23307766
[TBL] [Abstract][Full Text] [Related]
40. Impact on antiviral resistance of E119V, I222L and R292K substitutions in influenza A viruses bearing a group 2 neuraminidase (N2, N3, N6, N7 and N9).
Gaymard A; Charles-Dufant A; Sabatier M; Cortay JC; Frobert E; Picard C; Casalegno JS; Rosa-Calatrava M; Ferraris O; Valette M; Ottmann M; Lina B; Escuret V
J Antimicrob Chemother; 2016 Nov; 71(11):3036-3045. PubMed ID: 27432605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
